Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc > Desjardins puts MDG at buy
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(32)
•••
Comment by Indicatoron Jun 22, 2011 2:41pm
251 Views
Post# 18751574

RE: RE: Desjardins puts MDG at buy

RE: RE: Desjardins puts MDG at buywe've had the gamut here ... from $1.25 up to Paradigm's target:

February 17, 2011
"Paradigm Capital analyst Alan Ridgeway has assumed coverage of Medicago(TSX:MDG) with a “buy” rating and $2.50 price target."

Proof is in the pudding.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities